급성 EVD(External Ventricular Drain) 시장 규모, 점유율 및 동향 분석 보고서 : 용도별, 환자 유형별, 지역별 및 부문별 예측(2026-2033년)

Acute External Ventricular Drain Market Summary

The global acute external ventricular drain market size was estimated at USD 326.20 million in 2025 and is projected to reach USD 643.68 million by 2033, growing at a CAGR of 8.85% from 2026 to 2033. The growth is attributed to the rising incidence of traumatic brain injury, intracerebral hemorrhage, and hydrocephalus, along with increasing demand for real-time intracranial pressure monitoring in neurocritical care settings.

In addition, expanding neurosurgical infrastructure, greater availability of advanced drainage and monitoring systems, rising road traffic injuries, and increasing government investments in trauma and brain injury management programs are further supporting global market expansion.

Acquired Brain Injury (ABI) is a major clinical factor driving demand for acute external ventricular drains. Many ABI conditions lead to elevated intracranial pressure (ICP), hydrocephalus, or cerebrospinal fluid (CSF) accumulation, all of which require immediate pressure monitoring and fluid drainage. Conditions such as traumatic brain injury, stroke, brain tumors, and intracranial hemorrhage frequently result in acute neurological deterioration, requiring rapid neurosurgical intervention in intensive care settings. According to the World Health Organization, brain injuries and stroke remain leading causes of disability and mortality globally, increasing the need for critical neuro-monitoring devices. As hospital admissions for ABI rise due to aging populations, increasing road accidents, sports injuries, and better diagnostic detection, the need for emergency neurosurgical procedures also increases. Acute EVD systems are essential in these scenarios because they allow real-time ICP monitoring while simultaneously draining excess CSF, helping prevent secondary brain damage.

Global Acute External Ventricular Drain Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global acute external ventricular drain market report based on application, patient type, and region:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Traumatic Brain Injury
• Subarachnoid Hemorrhage
• Intracerebral Hemorrhage
• Other Non-traumatic Hydrocephalus Conditions
• Patient Type Outlook (Revenue, USD Million, 2021 - 2033)
• Pediatric
• Adult
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. Patient Type
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Acute External Ventricular Drain Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising incidence of brain injury
    • 3.2.1.2. Increasing elderly population
    • 3.2.1.3. Shift toward antimicrobial-coated and infection-prevention EVD systems
    • 3.2.1.4. Expansion of neurocritical care infrastructure
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Risk of catheter-associated infections
    • 3.2.2.2. Strict regulatory and clinical validation requirements
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Increasing demand for antimicrobial-coated EVD catheters
    • 3.2.3.2. Adoption of closed-system and pre-assembled disposable drainage kits
    • 3.2.3.3. Integration of digital intracranial pressure (ICP) monitoring technologies
    • 3.2.3.4. Expansion of neurotrauma and stroke care networks
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Need for continuous staff training in neurocritical care procedures
    • 3.2.4.2. Supply chain complexity for sterile neurosurgical consumables
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Acute External Ventricular Drain Market: Application Business Analysis

• 4.1. Application Market Share, 2025 & 2033
• 4.2. Application Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 4.4. Traumatic Brain Injury
  • 4.4.1. Traumatic Brain Injury Market, 2021 - 2033 (USD Million)
• 4.5. Subarachnoid Hemorrhage
  • 4.5.1. Subarachnoid Hemorrhage Market, 2021 - 2033 (USD Million)
• 4.6. Intracerebral Hemorrhage
  • 4.6.1. Intracerebral Hemorrhage Market, 2021 - 2033 (USD Million)
• 4.7. Other Non-traumatic Hydrocephalus Conditions
  • 4.7.1. Other Non-traumatic Hydrocephalus Conditions Market, 2021 - 2033 (USD Million)

Chapter 5. Acute External Ventricular Drain Market: Patient Type Estimates & Trend Analysis

• 5.1. Patient Type Market Share, 2025 & 2033
• 5.2. Patient Type Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Patient Type, 2025 to 2033 (USD Million)
• 5.4. Pediatric
  • 5.4.1. Pediatric Market, 2021 - 2033 (USD Million)
• 5.5. Adult
  • 5.5.1. Adult Market, 2021 - 2033 (USD Million)

Chapter 6. Acute External Ventricular Drain Market: Regional Estimates & Trend Analysis by Application and Patient Type

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
• 6.4. North America
  • 6.4.1. North America Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key country dynamic
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive insights
    • 6.4.2.4. U.S. Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key country dynamic
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive insights
    • 6.4.3.4. Canada Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key country dynamic
    • 6.4.4.2. Regulatory framework
    • 6.4.4.3. Competitive insights
    • 6.4.4.4. Mexico Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key country dynamic
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive insights
    • 6.5.2.4. UK Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key country dynamic
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive insights
    • 6.5.3.4. Germany Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key country dynamic
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive insights
    • 6.5.4.4. France Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key country dynamic
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive insights
    • 6.5.5.4. Italy Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key country dynamic
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive insights
    • 6.5.6.4. Spain Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.7. Denmark
    • 6.5.7.1. Key country dynamic
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive insights
    • 6.5.7.4. Denmark Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.8. Sweden
    • 6.5.8.1. Key country dynamic
    • 6.5.8.2. Regulatory framework
    • 6.5.8.3. Competitive insights
    • 6.5.8.4. Sweden Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.9. Norway
    • 6.5.9.1. Key country dynamic
    • 6.5.9.2. Regulatory framework
    • 6.5.9.3. Competitive insights
    • 6.5.9.4. Norway Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. China
    • 6.6.2.1. Key country dynamic
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive insights
    • 6.6.2.4. China Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.3. Japan
    • 6.6.3.1. Key country dynamic
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive insights
    • 6.6.3.4. Japan Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key country dynamic
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive insights
    • 6.6.4.4. India Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key country dynamic
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive insights
    • 6.6.5.4. South Korea Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key country dynamic
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive insights
    • 6.6.6.4. Australia Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key country dynamic
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive insights
    • 6.6.7.4. Thailand Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key country dynamic
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive insights
    • 6.7.2.4. Brazil Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key country dynamic
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive insights
    • 6.7.3.4. Argentina Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.4. Argentina
    • 6.7.4.1. Key country dynamic
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive insights
    • 6.7.4.4. Argentina Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Middle East and Africa
  • 6.8.1. Middle East and Africa Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8.2. Saudi Arabia
    • 6.8.2.1. Key country dynamic
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive insights
    • 6.8.2.4. Saudi Arabia Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8.3. UAE
    • 6.8.3.1. Key country dynamic
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive insights
    • 6.8.3.4. UAE Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8.4. South Africa
    • 6.8.4.1. Key country dynamic
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Competitive insights
    • 6.8.4.4. South Africa Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key country dynamic
    • 6.8.5.2. Regulatory framework
    • 6.8.5.3. Competitive insights
    • 6.8.5.4. Kuwait Acute External Ventricular Drain Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Share Analysis, 2025
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Spiegelberg GmbH & Co. KG (Luciole Medical AG)
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Medtronic
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Sophysa
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Suzhou Yaxin Medical products Co. Ltd.
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Natus Medical Incorporated
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Neuromedex GmbH
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Integra LifeSciences
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Delta Surgical
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Moller Medical
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. B. Braun SE
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives
  • 7.5.11. Fuji Systems
    • 7.5.11.1. Overview
    • 7.5.11.2. Financial Performance
    • 7.5.11.3. Product Benchmarking
    • 7.5.11.4. Strategic Initiatives
  • 7.5.12. DESU.
    • 7.5.12.1. Overview
    • 7.5.12.2. Financial Performance
    • 7.5.12.3. Product Benchmarking
    • 7.5.12.4. Strategic Initiatives